BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11805288)

  • 1. IL-6 transgenic mouse model for extraosseous plasmacytoma.
    Kovalchuk AL; Kim JS; Park SS; Coleman AE; Ward JM; Morse HC; Kishimoto T; Potter M; Janz S
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1509-14. PubMed ID: 11805288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
    McNeil N; Kim JS; Ried T; Janz S
    Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal translocations deregulating c-myc are associated with normal immune responses.
    Roschke V; Kopantzev E; Dertzbaugh M; Rudikoff S
    Oncogene; 1997 Jun; 14(25):3011-6. PubMed ID: 9223664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 and MYC collaborate in plasma cell tumor formation in mice.
    Rutsch S; Neppalli VT; Shin DM; DuBois W; Morse HC; Goldschmidt H; Janz S
    Blood; 2010 Mar; 115(9):1746-54. PubMed ID: 20018915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
    Lattanzio G; Libert C; Aquilina M; Cappelletti M; Ciliberto G; Musiani P; Poli V
    Am J Pathol; 1997 Sep; 151(3):689-96. PubMed ID: 9284817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
    Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA
    Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotype switch-mediated CH deletions are a recurrent feature of Myc/CH translocations in peritoneal plasmacytomas in mice.
    Kovalchuk AL; Janz S
    Int J Cancer; 2002 Oct; 101(5):423-6. PubMed ID: 12216069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cell tumour progression in iMycEmu gene-insertion mice.
    Kim JS; Han SS; Park SS; McNeil N; Janz S
    J Pathol; 2006 May; 209(1):44-55. PubMed ID: 16482495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph nodes and Peyer's patches of IL-6 transgenic BALB/c mice harbor T(12;15) translocated plasma cells that contain illegitimate exchanges between the immunoglobulin heavy-chain mu locus and c-myc.
    Kovalchuk AL; Kishimoto T; Janz S
    Leukemia; 2000 Jun; 14(6):1127-35. PubMed ID: 10865979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice.
    Suematsu S; Matsusaka T; Matsuda T; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):232-5. PubMed ID: 1729694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Implications for plasmacytoma induction.
    Rico-Vargas SA; Potter M; Osmond DG
    J Immunol; 1995 Mar; 154(5):2082-91. PubMed ID: 7868885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
    Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc translocations in B cell and plasma cell neoplasms.
    Janz S
    DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin/Myc recombinations in murine Peyer's patch follicles.
    Müller JR; Mushinski EB; Williams JA; Hausner PF
    Genes Chromosomes Cancer; 1997 Sep; 20(1):1-8. PubMed ID: 9290947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
    Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S
    Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S; Babonits M; Klein G
    Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
    Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
    Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 in myeloma/plasmacytoma.
    Suematsu S; Matsusaka T; Matsuda T; Hirano T; Kishimoto T
    Int Rev Exp Pathol; 1993; 34 Pt A():91-8. PubMed ID: 8454420
    [No Abstract]   [Full Text] [Related]  

  • 20. IgG1 plasmacytosis in interleukin 6 transgenic mice.
    Suematsu S; Matsuda T; Aozasa K; Akira S; Nakano N; Ohno S; Miyazaki J; Yamamura K; Hirano T; Kishimoto T
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7547-51. PubMed ID: 2798426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.